Picked up some DNDN Dendreon Jan 7.5 calls @ .32 and Feb 7.5 calls @ .45. I’m sure this will be spotlighted on Fast Money tonight.

The news:

“The congressional trio asked Rep. John Dingell, chairman of the House Energy and Commerce Committee, to probe allegations of conflicts of interest and ethical violations of at least two FDA advisory committee members that opposed approval of Provenge.

There was no word from Dingell’s office on whether the investigation will proceed, but investors sent Dendreon shares up 18 percent following a CNBC report on the matter.”

Source: CNBC

Thanks for reading

Want to know when I post again? Subscribe to the StockRake feed: .